BioSpace News Archive

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that it has entered into a non-binding letter of intent with a potential buyer for sale of substantially all of the assets of its US Compounding Inc. (USC) subsidiary. Under the terms described in the letter of intent, the buyer would agree to acquire substantially all of the assets of US Compounding in exchange for a total gross consideration that could range from approximately $

CARBAGLU is First and Only FDA-Approved Medication for Hyperammonemia Associated with These Rare Conditions

HCA Healthcare (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that it has formed a consortium of prominent public and private research institutions to use HCA Healthcare’s vast data on COVID-19 hospital care to improve patient outcomes and public knowledge.

Phoenix Children’s recently achieved accreditation as an Adult Congenital Heart Disease Comprehensive Care Center from the Adult Congenital Heart Association, a nationwide organization dedicated to education, advocacy and research to improve the lives of those born with heart defects.

Higher episodes of trauma accidents that incur serious injuries could bolster the demand for biomedical warming and thawing devices over the coming years.

The global blood preparation market growth will largely be driven by the escalating prevalence of blood-related conditions and rising number of chronic diseases such as cirrhosis among baby boomers.

Aphena Pharma Solutions announces that the continuing $21 million expansion of its Solid Dose Division in Cookeville, Tennessee, is progressing according to schedule, with a planned completion date of April 1.

270Surgical Ltd is pleased to announce that Scott Huennekens has joined the Board of Directors team as an Observer and will also act as an advisor to the Board and CEO effective immediately.

According to the WHO, as of October 2020, globally at least 1 billion people are suffering from near or far vision impairment.

The diabetic retinopathy market will witness significant expansion through the next few years with the prevalence of diabetic conditions across developing countries.